APR-246 overcomes resistance to cisplatin and doxorubicin in ovarian cancer cells

por Mohell, N, Alfredsson, J, Fransson, Å, Uustalu, M, Byström, S, Gullbo, J, Hallberg, A, Bykov, V J N, Björklund, U, Wiman, K G
Publicado 2015